{"resource":"https://api.magentlab.com/api/calc/hfa_icos_her2","service":"magent","areas":["other"],"answering":true,"http_status":402,"latency_ms":390,"price_usdc":0.005,"buyers_30d":1,"calls_30d":2,"description":"Lyon 2020 HFA-ICOS baseline cardiovascular risk before HER2-targeted therapy (trastuzumab and related agents). Very high, high, medium, or low from published factors plus Medium 1/2 points; expert-opinion cardiotoxicity guide <2% / 2-9% / 1","id":"3acb552826f2","category":"Calculators and conversions","accuracy":null,"tool_calls":null,"checked_day":"2026-10-11","page":"https://velliumandco.com/sellers/3acb552826f2"}